Evaluation for a ventricular assist device: Selecting the appropriate candidate

Circulation

Volumn 119, Issue 16, 2009, Pages 2225-2232

  Wilson, Sean R ^b   Mudge, Gilbert H ^a,b   Stewart, Garrick C ^a,b   Givertz, Michael M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; ASSISTED CIRCULATION; BODY SIZE; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CURRICULUM; DEVICE; DISEASE SEVERITY; EVALUATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART RIGHT VENTRICLE; HEART SEPTUM DEFECT; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIVER FUNCTION; LUNG FUNCTION; MEDICAL CARE; MITRAL VALVE REGURGITATION; NUTRITION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SELF CARE; SOCIAL WORK; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; HEART ASSIST DEVICE; HOSPITAL ADMISSION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR;

FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS; WAITING LISTS;

EID: 67449087184     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.850610     Document Type: Article

References (39)

1. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29: 2388-2442.
2. Allen LA, Rogers JG, Warnica JW, DiSalvo TG, Tasissa G, Binanay C, O'Connor CM, Califf RM, Leier CV, Shah MR, Stevenson LW. High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization. J Card Fail. 2008;14:661-669.
3. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics: 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117: e25-e146.
4. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424-1433.
5. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
6. Taylor DO, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Rahmel AO, Kucheryavaya AY, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant. 2008;27:943-956.
7. Medicare National Coverage Determination Manual: Chapter 1, Part 1 (Sections 10-80.12): Coverage Determination. Baltimore, Md: Centers for Medicaid & Medicare Services; 2008.
8. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
9. Gronda E, Bourge RC, Costanzo MR, Deng M, Mancini D, Martinelli L, Torre-Amione G, O'Hara ML, Chambers S. Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25: 1043-1056.
10. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese KA, Vargo RL, McCarthy PM, Rose EA, Levin HR. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995;92(suppl II):II-169-II-173.
11. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505.
12. Deng MC, Loebe M, El Banayosy A, Gronda E, Jansen PG, Vigano M, Wieselthaler GM, Reichart B, Vitali E, Pavie A, Mesana T, Loisance DY, Wheeldon DR, Portner PM. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103:231-237.
13. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, Ulisney K, Young JB. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27:1065-1072.
14. Kirklin JK, Naftel DC. Mechanical circulatory support: registering a therapy in evolution. Circ Heart Fail. 2008;1:200-205.
15. Stevenson LW, Couper G. On the fledgling field of mechanical circulatory support. JAm Coll Cardiol. 2007;50:748-751.
16. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME, Stevenson LW. Task Force 3: recipient guidelines/prioritization, in 24th Bethesda Conference: cardiac transplantation. JAm Coll Cardiol. 1993;22:21-31.
17. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, Savin S, Cordisco ME, Rose E, Oz M. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998;98:2383-2389.
18. Miller LW. Patient selection for the use of ventricular assist devices as a bridge to transplantation. Ann Thorac Surg. 2003; 75(suppl):S66-S71.
19. Cimato TR, Jessup M. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. J Heart Lung Transplant. 2002;21:1161-1173.
20. Mudge GH Jr, Fang JC, Smith C, Couper G. The physiologic basis for the management of ventricular assist devices. Clin Cardiol. 2006;29:285-289.
21. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score: a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. JAm Coll Cardiol. 2008;51:2163-2172.
22. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, Oz MC, Naka Y. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1-6.
23. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos R, Naftel DC, Kirklin JK, Taylor DO. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant. 2005;24:1182-1187.
24. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, Hsu AP, Yeager ML, Buda T, Hoercher KJ, Howard MW, Takagaki M, Doi K, Fukamachi K. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106(suppl I):I-198-I-202.
25. Nakatani S, Thomas JD, Savage RM, Vargo RL, Smedira NG, McCarthy PM. Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation. 1996;94(suppl II):II-216-II-221.
26. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg. 1999;68:2181-2184.
27. Potapov EV, Stepanenko A, Dandel M, Kukucka M, Lehmkuhl HB, Weng Y, Hennig F, Krabatsch T, Hetzer R. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 2008;27:1275-1281.
28. Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994;24: 1688-1691.
29. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45: 1428-1434.
30. Masai T, Sawa Y, Ohtake S, Nishida T, Nishimura M, Fukushima N, Yamaguchi T, Matsuda H. Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation. Ann Thorac Surg. 2002;73:549-555.
31. Reinhartz O, Farrar DJ, Hershon JH, Avery GJ Jr, Haeusslein EA, Hill JD. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg. 1998; 116:633-640.
32. Butler J, Geisberg C, Howser R, Portner PM, Rogers JG, Deng MC, Pierson RN III. Relationship between renal function and left ventricular assist device use. Ann Thorac Surg. 2006;81:1745-1751.
33. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg. 2003;125:855-862.
34. El Banayosy A, Arusoglu L, Kizner L, Tenderich G, Boethig D, Minami K, Korfer R. Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: a single-center retrospective study on more than 100 patients. J Heart Lung Transplant. 2000;19:964-968.
35. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526-534.
36. Dang NC, Topkara VK, Kim BT, Lee BJ, Remoli R, Naka Y. Nutritional status in patients on left ventricular assist device support. J Thorac Cardiovasc Surg. 2005; 130:e3-e4.
37. Holdy K, Dembitsky W, Eaton LL, Chillcott S, Stahovich M, Rasmusson B, Pagani F. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant. 2005;24:1690-1696.
38. Mielniczuk L, Mussivand T, Davies R, Mesana TG, Masters RG, Hendry PJ, Keon WJ, Haddad HA. Patient selection for left ventricular assist devices. Artif Organs. 2004;28:152-157.
39. Dew MA, DiMartini AF, Steel J, De Vito DA, Myaskovsky L, Unruh M, Greenhouse J. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14: 159-172.